Please use this identifier to cite or link to this item: http://elea.unisa.it:8080/xmlui/handle/10556/2191
Title: Synthesis of novel ligands for the stabilization of organometallic complexes having potential antitumor activity
Authors: Caporale, Angelamaria
Sbardella, Gianluca
Saturnino, Carmela
Keywords: Group III metal complexes
Gold complexes
Issue Date: 4-May-2016
Publisher: Universita degli studi di Salerno
Abstract: The design of new metal complexes as anticancer agents has received considerable interest in recent years. Complexes of titanium (e.g.: titanocene dichloride), lanthanides complexes (e.g.: texaphyrrins lanthanide) and carbenic complexes of gold, silver and copper showed significant biological activity, and have progressed into clinical trials. Thus, the target of this PhD project are the synthesis of new ligands and metal complexes. Firstly 5 cyclopentadienyl pro-ligands were synthesised: 6-phenylfulvene, 6-(p-metoxyphenyl)-fulvene e 6- (3',4'-dymethoxyphenyl)fulvene, 6-(3',5')-dymethoxyphenyl)fulvene and 6-(2',4')- dymethoxyphenyl)fulvene. Then, the synthesis of 12 novel scandium, yttrium and neodymium complexes with these cyclopentadienyl ligands was carried out. The complexes were tested on DU146 (Prostatic carcinoma) and MDA.MB213 (Breast cancer) to verify inhibition of cell-proliferation, using MTT test with standard procedures. All the complex showed a strong concentration-dependent ability of inhibiting the growth tumor cell, referring to antiblastic activity. [edited by author]
Description: 2014 - 2015
URI: http://hdl.handle.net/10556/2191
Appears in Collections:Scienze farmaceutiche

Files in This Item:
File Description SizeFormat 
tesi A. Caporale.pdftesi di dottorato2,54 MBAdobe PDFView/Open
abstract in italiano A. Caporale.pdfabstract in italiano a cura dell'autore182,73 kBAdobe PDFView/Open
abstract in inglese A. Caporale.pdfabstract in inglese a cura dell'autore29,23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.